SecBot SecBot

MPLT drug pipeline

$6.90
−4.8% 1-day · Nov 16
Next catalyst
None dated
No dated FDA catalyst on file
Typical move on FDA news
±5.4%
1-day, median of 1 event
IV rank
No data
No current options data
Rated drugs
2
1 bearish · 1 mixed
Phase 3 trials
0
0 with results posted

Drugs

soonest catalyst first

Fresh Drug Report

This drug report is still fresh. Subscribe to read its impact, phase, bull and bear case and thesis.

Subscribe for Full Access

Fresh Drug Report

This drug report is still fresh. Subscribe to read its impact, phase, bull and bear case and thesis.

Subscribe for Full Access

Past FDA events & how the stock moved

1 events
DateDrugEvent1 day5 days
Dec 1, 2025ML-007C-MAFast Track−5.4%+35.4%

Clinical trials

2 Phase 2/3
DrugTrialPhaseStatusEnrolledPrimary completion
ML-007C-MA BIDA Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With SchizophreniaPhase 2Completed307Jun 4, 2026
ML-004ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)Phase 2Completed168Mar 10, 2026